Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Empoli

8 clinical trials in Empoli, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Empoli at a glance
8
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

8 trials in Empoli

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Capivasertib
  • Sponsor:Relay Therapeutics Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Immunoglobulin A
  • Sponsor:Azienda Ospedaliero Universitaria Di Modena
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Hamilton Health Sciences Corporation
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Anastrozole
  • Sponsor:University Of Florence
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Empoli

What the registry says about research in the country

01 Breast Cancer Research

Comprehensive studies focusing on triple-negative breast cancer (TNBC) and various treatment approaches for different breast cancer subtypes.

  • Advanced TNBC Treatments
  • Early-Stage Breast Cancer
  • Hormone Receptor Studies

Novel therapeutic combinations being evaluated, including targeted therapies and immunotherapy approaches for better patient outcomes.

02 Targeted Therapies

Innovative research examining hormone receptor-positive and HER2-negative breast cancers, with particular focus on endocrine therapy optimization.

  • Pre-surgical Treatment Strategies
  • Combination Therapy Approaches
  • Personalized Treatment Plans

Evaluating new therapeutic agents for improved treatment efficacy in specific breast cancer subtypes.

03 Additional Clinical Areas

Diverse research portfolio including studies on septic shock and colorectal cancer treatments.

  • Immunoglobulin Therapy
  • Metastatic Colorectal Cancer
  • Personalized Medicine Approaches

Investigation of targeted therapies and biomarker-driven treatment selection in various conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.